These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2478793

  • 1. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF, Grom E, Jähnchen E, Roskamm H.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G, Ningel K, Permanetter B.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
    Permanetter B, Sebening H, Hartmann F, Klein G.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
    [Abstract] [Full Text] [Related]

  • 4. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I, Kassel P, Duck HG, Fiehring H, Morgan P, Schmidt PK, Höfs T, Nehmiz G.
    Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
    [Abstract] [Full Text] [Related]

  • 5. Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure.
    Hagemeijer F, Roth W, Brand HJ.
    J Cardiovasc Pharmacol; 1989 Nov; 14 Suppl 2():S57-64. PubMed ID: 2478794
    [Abstract] [Full Text] [Related]

  • 6. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B, Sebening H, Busch U, Lutilsky L.
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [Abstract] [Full Text] [Related]

  • 7. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure].
    Tsuda T, Izumi T, Kodama M, Hanawa H, Ohshima M, Takahashi M, Suzuki M, Aizaki T, Uchiyama H, Shibata A.
    J Cardiol; 1992 Aug; 22(4):721-9. PubMed ID: 1343639
    [Abstract] [Full Text] [Related]

  • 8. [Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure].
    Bergler-Klein J, Globits S, Stefenelli T, Mayr H, Porenta G, Sochor H, Glogar D.
    Z Kardiol; 1992 Oct; 81(10):546-52. PubMed ID: 1441695
    [Abstract] [Full Text] [Related]

  • 9. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM, Lynch JJ, Driscoll EM, Lucchesi BR.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunction.
    Remme WJ, Wiesfeld AC, Look MP, Kruyssen HA.
    J Cardiovasc Pharmacol; 1989 Mar; 14 Suppl 2():S41-4. PubMed ID: 2478791
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC, Diederen W.
    J Cardiovasc Pharmacol; 1989 Mar; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [Abstract] [Full Text] [Related]

  • 12. [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
    Volpini M, Gargano M, Cuccia C, Dei Cas L, Gei P, Metra M, Moretti R, Riva S.
    Cardiologia; 1989 Jun; 34(6):517-23. PubMed ID: 2676168
    [Abstract] [Full Text] [Related]

  • 13. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M.
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [Abstract] [Full Text] [Related]

  • 14. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M, Eugène M, Evans J, Laurenceau JL, Hubermann JP, Thomas D, Drobinski G, Leprince JL, Ganty J, Wajman A, Guedj D, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [Abstract] [Full Text] [Related]

  • 15. [Hemodynamic and clinical effects of captopril in congestive heart failure].
    Galiè N, Magelli C, Ribani MA, Bassein L, Sanguinetti M, Magnani B.
    G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
    [Abstract] [Full Text] [Related]

  • 16. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
    Pouleur H, Hanet C, Schröder E, Col J, Van Mechelen H, Etienne J, Rousseau MF.
    J Cardiovasc Pharmacol; 1989 Jan; 14 Suppl 2():S18-22. PubMed ID: 2478787
    [Abstract] [Full Text] [Related]

  • 17. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].
    Permanetter B, Baumann G, Wirtzfeld A, Günes S, Stinshoff M, Klein G.
    Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
    Figulla HR, Luig H, Nieschlag F, Kreuzer H.
    Z Kardiol; 1987 Mar; 76(3):167-74. PubMed ID: 3109142
    [Abstract] [Full Text] [Related]

  • 19. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G, Holubarsch C, Heiss HW, Allgeier M, Just H.
    J Cardiovasc Pharmacol; 1989 Mar; 14 Suppl 2():S31-5. PubMed ID: 2478789
    [Abstract] [Full Text] [Related]

  • 20. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.